3 Reasons DRS is Risky and 1 Stock to Buy Instead
Leonardo DRS has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 23.1% and now trades at $34.97. This was partly thanks to its solid quarterly r
3 Reasons to Avoid ST and 1 Stock to Buy Instead
Over the past six months, Sensata Technologies’s stock price fell to $28.40. Shareholders have lost 19.7% of their capital, disappointing when considering the S&P 500 was flat. This might have inves
3 Reasons to Sell PEGA and 1 Stock to Buy Instead
Pegasystems has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 6.7% and now trades at $72.71. This was partly thanks to its solid quarterly res
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks
Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.
Spotting Winners: TreeHouse Foods (NYSE:THS) And Shelf-Stable Food Stocks In Q4
Let’s dig into the relative performance of TreeHouse Foods (NYSE:THS) and its peers as we unravel the now-completed Q4 shelf-stable food earnings season.
3 Reasons to Avoid ADT and 1 Stock to Buy Instead
ADT has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 9.2% and now trades at $7.92. This was partly thanks to its solid quarterly results, and
3 Reasons to Sell STE and 1 Stock to Buy Instead
STERIS currently trades at $226.40 per share and has shown little upside over the past six months, posting a small loss of 4.5%.
3 Reasons QTWO is Risky and 1 Stock to Buy Instead
Q2 Holdings has been treading water for the past six months, recording a small loss of 4.1% while holding steady at $78.18.
Q4 Earnings Highs And Lows: First Solar (NASDAQ:FSLR) Vs The Rest Of The Renewable Energy Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at First Solar (NASDAQ:FSLR) and its peers.
3 Reasons to Avoid HNST and 1 Stock to Buy Instead
The past six months have been a windfall for The Honest Company’s shareholders. The company’s stock price has jumped 44.3%, hitting $5.34 per share. This was partly due to its solid quarterly resu